![Structure, Synthesis and Inhibition Mechanism of Nucleoside Analogues as HIV‐1 Reverse Transcriptase Inhibitors (NRTIs) - Yoshida - 2021 - ChemMedChem - Wiley Online Library Structure, Synthesis and Inhibition Mechanism of Nucleoside Analogues as HIV‐1 Reverse Transcriptase Inhibitors (NRTIs) - Yoshida - 2021 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/36e5cd8f-f19e-490c-b8e8-6c7bb170007f/cmdc202000695-toc-0001-m.png)
Structure, Synthesis and Inhibition Mechanism of Nucleoside Analogues as HIV‐1 Reverse Transcriptase Inhibitors (NRTIs) - Yoshida - 2021 - ChemMedChem - Wiley Online Library
![Frontiers | Reverse Transcriptase Mechanism of Somatic Hypermutation: 60 Years of Clonal Selection Theory Frontiers | Reverse Transcriptase Mechanism of Somatic Hypermutation: 60 Years of Clonal Selection Theory](https://www.frontiersin.org/files/MyHome%20Article%20Library/305068/305068_Thumb_400.jpg)
Frontiers | Reverse Transcriptase Mechanism of Somatic Hypermutation: 60 Years of Clonal Selection Theory
![Endogenous LINE-1 (Long Interspersed Nuclear Element-1) Reverse Transcriptase Activity in Platelets Controls Translational Events Through RNA–DNA Hybrids | Arteriosclerosis, Thrombosis, and Vascular Biology Endogenous LINE-1 (Long Interspersed Nuclear Element-1) Reverse Transcriptase Activity in Platelets Controls Translational Events Through RNA–DNA Hybrids | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/578603ec-77ea-4802-acd7-3db9ab3aeb69/16ga01.jpg)
Endogenous LINE-1 (Long Interspersed Nuclear Element-1) Reverse Transcriptase Activity in Platelets Controls Translational Events Through RNA–DNA Hybrids | Arteriosclerosis, Thrombosis, and Vascular Biology
![Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum](https://cdn.hiv.uw.edu/doc/468-1/nucleoside-reverse-transcriptase-inhibitors.jpg)
Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum
![HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions](https://static-02.hindawi.com/articles/mbi/volume-2012/586401/figures/586401.fig.001.jpg)
HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions
![Rational in silico drug design of HIV-RT inhibitors through G-QSAR and molecular docking study of 4-arylthio and 4-aryloxy-3-iodopyridine-2(1-H)-one derivative | Beni-Suef University Journal of Basic and Applied Sciences | Full Text Rational in silico drug design of HIV-RT inhibitors through G-QSAR and molecular docking study of 4-arylthio and 4-aryloxy-3-iodopyridine-2(1-H)-one derivative | Beni-Suef University Journal of Basic and Applied Sciences | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs43088-020-00075-7/MediaObjects/43088_2020_75_Fig1_HTML.png)